EMA consults on ICH M12 guideline for drug-drug interaction studies
Regulatory NewsJeff Craven
Clinical TrialsEuropeGlobalPharmaceuticalsPreclinical studyProduct LifecycleRegulatory NewsJeff CravenClinical TrialsEuropeGlobalPharmaceuticalsPreclinical studyProduct Lifecycle